Medizone Home
×
International Pharma Supplies Analytical Samples for Biosimilar Development Unlicensed Medicines Supplies Comparator Sourcing for clinical trials

International Pharma Supplies

We supply prescription only and OTC products to authorized wholesalers, licensed importers and aid organisations – from anywhere in the EU with a focus on German products.

Analytical Samples for Biosimilar Development

We supply analytical samples for Biosimilar development from almost anywhere in the world – Multi-country, Multi-batch and Multi-expiry date approach.

Unlicensed Medicines Supplies

We supply prescription only and OTC products to companies that have specialized in unlicensed medicines supplies, government agencies, hospitals and pharmacies.

Comparator Sourcing for clinical trials

We source Comparator products from almost anywhere in the World and have direct access to many innovators and approved supply sources.

Meet us at our booth at ARAB HEALTH 2017 – 30th Jan to 2nd Feb

We are looking forward to welcoming you at our booth at ARAB HEALTH - Stand No. Z3.E39 in the "German Hall". 30th January to 2nd February 2017. For more information visit ARAB HEALTH exhibitor ...

Mylan and Biocon filed the biosimilar Herceptin application to FDA

Mylan N.V. and Biocon Ltd. last week announced submission of Mylan’s biologics license application (BLA) for MYL-1401O, a proposed biosimilar trastuzumab, to the U.S. Food and Drug Administration (FDA) ...

FDA approves Sandoz’ Enbrel Biosimilar

The U.S. Food and Drug Administration approved Erelzi, (etanercept-szzs) for multiple inflammatory diseases. Erelzi is a biosimilar to Enbrel (etanercept), which was originally licensed in 1998. The newly ...

Coherus BioSciences announces positive Phase III results for CHS-1420 (Humira biosimilar candidate) in psoriasis patients

Coherus BioSciences, Inc., reported topline results from an ongoing Phase 3 clinical study of CHS-1420, an adalimumab (Humira) biosimilar candidate. The study met its primary endpoint demonstrating ...